We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Cortisol Identified as Biomarker for Severe Depression in Teenage Boys

By LabMedica International staff writers
Posted on 04 Mar 2014
Print article
A team of British neuroscientists has found a dynamic link between high levels of the hormone cortisol and chronic depression, especially among teenage boys.

Clinical depression is a severe and common illness, characterized primarily by a persistent low mood and lack of pleasure in usually enjoyable activities, which results in significant impairment in everyday living. It also involves alterations in cognitive and hormonal functions. There is substantial variation between depressed individuals in terms of the causes and therapeutic response, making it difficult to identify those most likely to benefit from intervention and treatment.

Cortisol (hydrocortisone) is a glucocorticoid hormone, produced by the zona fasciculata of the adrenal gland. It is released in response to stress and a low level of blood glucocorticoids. Its primary functions are to increase blood sugar through gluconeogenesis; suppress the immune system; and aid in fat, protein, and carbohydrate metabolism.

Investigators at the University of Cambridge (United Kingdom) sought to identify biochemical markers that could be linked to depression. Towards this end, they measured cortisol levels in saliva samples obtained from two groups of teenagers. The first group of 660 provided samples on four school mornings within a week and then again 12 months later. A second group of 1,198 teenagers gave samples over three school mornings. Over the time period, the participants were asked to fill out a questionnaire designed to reveal symptoms of depression.

The participants were separated into four subgroups determined by combining cortisol results with data from the questionnaires. Group I was comprised of individuals with normal levels of cortisol and low symptoms of depression while Group IV was composed of those with elevated cortisol and severe symptoms of depression. Results of the analysis revealed that those in Group IV were on average seven times more likely than those in Group I, and two to three times more likely than in the other two groups, to develop clinical depression. Further analysis showed that boys in Group IV were 14 times more likely to develop clinical depression than those in Group I, and two to four times more likely to develop it than boys in either of the other two groups.

"Depression is a terrible illness," said senior author Dr. Ian Goodyer, professor of adolescent psychiatry at the University of Cambridge. "[And] we now have a very real way of identifying those teenage boys most likely to develop clinical depression. Armed with such knowledge, doctors and other caregivers could target prevention strategies at depression-vulnerable boys and hopefully help reduce their risk of serious episodes of depression and their consequences in adult life."

The study was published in the February 18, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

University of Cambridge


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.